DE202011110859U1 - Kleine Peptide umfassendes Zellkulturmedium - Google Patents

Kleine Peptide umfassendes Zellkulturmedium Download PDF

Info

Publication number
DE202011110859U1
DE202011110859U1 DE202011110859.0U DE202011110859U DE202011110859U1 DE 202011110859 U1 DE202011110859 U1 DE 202011110859U1 DE 202011110859 U DE202011110859 U DE 202011110859U DE 202011110859 U1 DE202011110859 U1 DE 202011110859U1
Authority
DE
Germany
Prior art keywords
cells
cell
cell culture
cysteine
feed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE202011110859.0U
Other languages
German (de)
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44816118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE202011110859(U1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Publication of DE202011110859U1 publication Critical patent/DE202011110859U1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE202011110859.0U 2010-04-23 2011-04-22 Kleine Peptide umfassendes Zellkulturmedium Expired - Lifetime DE202011110859U1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32764410P 2010-04-23 2010-04-23
US61/327,644 2010-04-23
US13/092,016 US20110262965A1 (en) 2010-04-23 2011-04-21 Cell culture medium comprising small peptides
US13/092,016 2011-04-21

Publications (1)

Publication Number Publication Date
DE202011110859U1 true DE202011110859U1 (de) 2016-12-20

Family

ID=44816118

Family Applications (1)

Application Number Title Priority Date Filing Date
DE202011110859.0U Expired - Lifetime DE202011110859U1 (de) 2010-04-23 2011-04-22 Kleine Peptide umfassendes Zellkulturmedium

Country Status (10)

Country Link
US (6) US20110262965A1 (https=)
EP (4) EP3165600B1 (https=)
JP (7) JP6016783B2 (https=)
KR (6) KR102109463B1 (https=)
CN (3) CN106520658B (https=)
AU (6) AU2011242496C1 (https=)
DE (1) DE202011110859U1 (https=)
DK (3) DK3165600T3 (https=)
SG (3) SG10201609347RA (https=)
WO (1) WO2011133902A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10793827B2 (en) 2010-04-23 2020-10-06 Life Technologies Corporation Cell culture medium comprising small peptides

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2012017925A1 (ja) * 2010-08-02 2013-10-03 協和発酵キリン株式会社 物質の製造方法
EP2601287B1 (en) 2010-08-05 2015-01-07 Amgen Inc. Dipeptides to enhance yield and viability from cell cultures
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CN104080905B (zh) 2011-12-22 2016-11-16 生命技术公司 细胞培养基和方法
CN102533634A (zh) * 2012-02-22 2012-07-04 江阴剑桥生物技术有限公司 Cho细胞无血清无蛋白化学培养基
AU2013240972A1 (en) 2012-03-30 2014-10-30 Ajinomoto Co., Inc. Culture medium for proliferating stem cell, which contains sulfated compound
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013166339A1 (en) * 2012-05-02 2013-11-07 Life Technologies Corporation High yield transient expression in mammalian cells using unique pairing of high density growth and transfection medium and expression enhancers
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
JP6195191B2 (ja) * 2013-08-08 2017-09-13 極東製薬工業株式会社 無タンパク質・無脂質培地馴化細胞株を用いた組換えタンパク質の製造方法
JP6190205B2 (ja) * 2013-08-08 2017-08-30 極東製薬工業株式会社 無タンパク質・無脂質培地馴化細胞株、その製造方法及び培地
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
CN104593318B (zh) * 2013-10-31 2018-05-04 中国食品发酵工业研究院 一种用于细胞培养基的玉米活性肽添加剂
US9534026B2 (en) 2013-10-31 2017-01-03 China National Research Institute Of Food & Fermentation Industries Corn active peptide additive for cell culture medium
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
RU2016144057A (ru) * 2014-04-10 2018-05-15 Байер Хелскеа Ллк Смешанный состав порошка среды и способ получения жидкой среды для культуры клеток
WO2015175672A1 (en) * 2014-05-14 2015-11-19 Merial, Inc. Methods for freeze-drying and rehydrating biologics
BR112016027797A2 (pt) * 2014-06-18 2017-10-31 Medimmune Llc métodos e meios de cultura de células compreendendo n-acetilcisteína
RU2725191C2 (ru) * 2014-08-11 2020-06-30 Ф. Хоффманн-Ля Рош Аг Способ повышения удельной скорости и продуцирования в эукариотических клетках
EP3303555B1 (en) * 2015-05-29 2020-06-24 Merck Patent GmbH Deep eutectic solvents and/or ionic liquids in cell culture media
US20180312802A1 (en) * 2015-11-02 2018-11-01 Ares Trading S.A. Methods for modulating production profiles of recombinant proteins in perfusion mode
US20190055513A1 (en) * 2016-02-22 2019-02-21 Agency For Science, Technology And Research Cell culture medium
CN107760651A (zh) * 2016-08-23 2018-03-06 四川科伦博泰生物医药股份有限公司 一种细胞培养基及生产蛋白质的方法
DE102017203908B3 (de) * 2017-03-09 2018-05-30 Evonik Technochemie Gmbh Kulturmedium, umfassend Oligopeptide
DK3372670T3 (da) * 2017-03-09 2019-05-20 Evonik Technochemie Gmbh Dyrkningsmedier, der omfatter n-acyl-x-glutamindipeptider
DK3372671T3 (da) 2017-03-09 2022-01-24 Evonik Operations Gmbh Dyrkningsmedium, som omfatter oligopeptider
CA3058306A1 (en) * 2017-03-28 2018-10-04 Ajinomoto Co., Inc. Additive for undifferentiation maintaining medium
CN106978390B (zh) * 2017-05-22 2020-11-13 广东顺德工业设计研究院(广东顺德创新设计研究院) 适用于贴壁型cho细胞的无血清培养基及培养方法
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
CN107278892A (zh) * 2017-06-26 2017-10-24 浦江县美泽生物科技有限公司 紫玉兰的高效组织培养方法
CN111201315B (zh) * 2017-10-13 2023-10-03 勃林格殷格翰国际公司 灌注培养基
WO2019099891A1 (en) * 2017-11-16 2019-05-23 Life Technologies Corporation Streamlined methods for making liquid media
KR20200100108A (ko) * 2017-12-20 2020-08-25 바스프 에스이 양친매성 그라프트 공중합체를 세포 배양 시약으로 이용하여 세포 배양 시스템을 안정화하는 방법
CN112352046A (zh) * 2018-06-29 2021-02-09 长濑产业株式会社 麦角硫因、抗坏血酸2-葡糖苷、抗坏血酸和它们的组合的成肌分化促进作用
JP7197339B2 (ja) * 2018-12-05 2022-12-27 アサヒグループ食品株式会社 コク味付与物質含有酵母の製造方法及びコク味付与物質含有酵母エキスの製造方法
CN109628378B (zh) * 2019-01-25 2020-07-17 江苏丰华生物制药有限公司 一种利用花生蛋白酶解物培养cho细胞的方法
AU2021259110B2 (en) * 2020-04-20 2026-04-02 Evonik Operations Gmbh Compositions comprising Cys-peptides
GB202012991D0 (en) * 2020-08-20 2020-10-07 Ucb Biopharma Sprl Cell culture processes
KR20240055110A (ko) * 2021-09-15 2024-04-26 에보닉 오퍼레이션스 게엠베하 디펩티드 및 미량 원소를 포함하는 조성물
CA3233315A1 (en) 2021-10-05 2023-04-13 Evonik Operations Gmbh Salts of dipeptides and their uses in cell culture
AU2023227353B2 (en) 2022-03-03 2026-02-12 Evonik Operations Gmbh Process to enhance viral vector production in cell-culture using glycyl-glutamine
AU2022458001A1 (en) * 2022-05-12 2025-01-02 Evonik Operations Gmbh Photostabilized compositions and a method for stabilizing photosensitive components
EP4665839A1 (en) * 2023-02-16 2025-12-24 Merck Patent GmbH Cell culture media
KR102609654B1 (ko) * 2023-03-23 2023-12-05 코스맥스 주식회사 인간 피부 유래 산물을 포함하는 미생물 배양 배지 및 이를 이용하여 배양된 혼합 미생물 배양액의 피부 개선 용도
GB202318647D0 (en) 2023-12-06 2024-01-17 Ucb Biopharma Sprl Cell culture processes
WO2025219232A1 (en) * 2024-04-15 2025-10-23 Evonik Operations Gmbh Application of small peptides supplemented cell culture media for improved cell performance
CN118956737A (zh) * 2024-07-17 2024-11-15 广州沃亘生物科技有限公司 一种长期维持df-1细胞活力的培养基及其用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534538A (en) 1990-07-12 1996-07-09 Degussa Aktiengesellschaft N-acyl dipeptides and their compositions
WO1998008934A1 (en) 1996-08-30 1998-03-05 Life Technologies, Inc. Serum-free mammalian cell culture medium, and uses thereof
US20050287666A1 (en) 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
US20070254358A1 (en) 2001-03-27 2007-11-01 Invitrogen Corporation Culture medium for cell growth and transfection

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235772A (en) * 1978-06-21 1980-11-25 Ab Kabi Novel peptides having growth promoting activity
DE3206784C2 (de) 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
DE3206810C2 (de) * 1982-02-25 1983-12-29 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen N ↑2↑-L-Tyrosinyl-N ↑6↑-L-tyrosinyl-L-lysin und N ↑2↑-L-Cystinyl-N ↑6↑-L-cystinyl-L-lysin, Verfahren zu deren Herstellung und deren Verwendung
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
EP0243469A4 (en) * 1985-10-22 1988-02-16 Plant Genetics Inc Methods and media for enhanced somatic embryogenesis.
DE3538310A1 (de) 1985-10-28 1987-04-30 Pfrimmer Pharma Verwendung von glutamin in form seiner di- und tripeptide im naehrmedium fuer zellkulturen
AU605214B2 (en) * 1986-10-24 1991-01-10 Fresenius Kabi Ab N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
CA2081023A1 (en) * 1990-04-23 1991-10-24 Mary A. Hilton Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
US5206220A (en) 1990-04-23 1993-04-27 Research Corporation Technologies, Inc. Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
US5328844A (en) * 1990-05-09 1994-07-12 University Of Colorado Foundation, Inc. Culture media for mammalian cells
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB2251249B (en) 1990-12-28 1995-06-21 Mogam Biotech Res Inst High-density medium for animal cell culture
DE69608668T2 (de) * 1995-02-23 2001-02-01 Quest International B.V., Naarden Peptide für gewebe- und zellkulturmedien
UA68327C2 (en) * 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
US20030130195A1 (en) * 2000-01-27 2003-07-10 Universite Laval Enzymatic hydrolysate of milk proteins
US6759510B1 (en) 2000-06-30 2004-07-06 Becton, Dickinson And Company Peptides for use in culture media
BR0116330A (pt) * 2000-12-20 2004-02-25 Novartis Ag Inibidores da interação e2f-1/ciclina para terapia de câncer
US20030232430A1 (en) * 2001-11-26 2003-12-18 Advanced Cell Technology Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
EP1492891B1 (en) 2002-03-29 2008-02-20 Merck & Co., Inc. Methods of virus production
DE60335024D1 (de) * 2002-12-23 2010-12-30 Bristol Myers Squibb Co Produktqualitätsverbesserung in säugerzellkulturverfahrenzur proteinproduktion
KR20040077553A (ko) * 2003-02-28 2004-09-04 독립행정법인농업생물자원연구소 견 단백질로부터 세포 생육 펩티드의 추출과 이용
WO2006028480A1 (en) * 2004-09-07 2006-03-16 Clonex Development, Inc. Cell lines for use in increasing protein yield form a cell culture
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
BRPI0519172A2 (pt) * 2004-12-20 2008-12-30 Ajimoto Kk proteÍna mutante, polinucleotÍdeo, microorganismo transformado, e, mÉtodos de produzir uma proteÍna mutante, um peptÍdeo, e alfa-l-aspartil-l-fenilalanina-beta-Éster, e de projetar e produzir uma proteÍna mutante
TWI456062B (zh) * 2006-09-13 2014-10-11 Abbvie Inc 細胞培養改良
WO2008105931A2 (en) 2006-09-15 2008-09-04 Medimmune Vaccines, Inc. Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
WO2008035631A1 (fr) * 2006-09-20 2008-03-27 Kyowa Hakko Kogyo Co., Ltd. Procédé de production d'une substance
ES2538986T3 (es) * 2006-11-08 2015-06-25 Wyeth Llc Medios diseñados racionalmente para un cultivo celular
TWI601823B (zh) 2007-04-26 2017-10-11 中外製藥股份有限公司 Cell culture methods using media containing high concentrations of amino acids
JP2008276843A (ja) 2007-04-27 2008-11-13 Hitachi Ltd レーザー駆動方法及び光ディスク記録再生装置
AU2008251405B2 (en) * 2007-05-11 2012-05-17 Amgen Inc. Improved feed media
EP2173860A1 (en) 2007-08-03 2010-04-14 Campina Nederland Holding B.V. Culture medium for eukaryotic cells
JP4911523B2 (ja) * 2007-10-22 2012-04-04 国立大学法人群馬大学 温度応答性配列を含むデプシペプチド構造と親水性高分子構造からなるブロック共重合体
WO2009060620A1 (ja) * 2007-11-08 2009-05-14 Fujifilm Corporation ポリペプチドの製造方法
JP5270239B2 (ja) * 2008-07-08 2013-08-21 不二製油株式会社 ペプチド性脂質低下剤
US8252557B2 (en) 2008-10-28 2012-08-28 Chugai Seiyaku Kabushiki Kaisha Peptide-containing culture medium for culturing animal cell
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
JPWO2012017925A1 (ja) * 2010-08-02 2013-10-03 協和発酵キリン株式会社 物質の製造方法
EP2601287B1 (en) * 2010-08-05 2015-01-07 Amgen Inc. Dipeptides to enhance yield and viability from cell cultures

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534538A (en) 1990-07-12 1996-07-09 Degussa Aktiengesellschaft N-acyl dipeptides and their compositions
WO1998008934A1 (en) 1996-08-30 1998-03-05 Life Technologies, Inc. Serum-free mammalian cell culture medium, and uses thereof
US20070254358A1 (en) 2001-03-27 2007-11-01 Invitrogen Corporation Culture medium for cell growth and transfection
US20050287666A1 (en) 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
Battista, P. J. et al., Am. Biotech Lab. 12: 64–68 (1994)
Brown et al., J. Chrom. (1994) A, 661: 279–285
Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, 15–40 (Sadettin Ozturk und Wei-Shou Hu Hrsg., Taylor and Francis Group 2006)
Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, 156–174 (Sadettin Ozturk und Wei-Shou Hu Hrsg., Taylor and Francis Group 2006)
Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, 349–386 (Sadettin Ozturk und Wei-Shou Hu Hrsg., Taylor and Francis Group 2006)
Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, 42–50 (Sadettin Ozturk und Wei-Shou Hu Hrsg., Taylor and Francis Group 2006)
Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, 51 (Sadettin Ozturk und Wei-Shou Hu Hrsg., Taylor and Francis Group 2006)
Cell Culture Technology for Pharmaceutical and Cell-Based Therapies, 52, Sadettin Ozturk und Wei-Shou Hu Hrsg., Taylor and Francis Group (2006)
Eagle et al., Science 130: 432–37 (1959)
Jun Qu, Yiming Wang, Guan Luo, Zhuping Wu und Chengdui Yang, Anal. Chem. 2002, 74, 2034–2040
Kao, F.-T. und Puck, T. T., Proc. Natl. Acad. Sci. USA 60: 1275–1281 (1968)
Roth et al., In Vitro Cellular & Developmental Biology 24(7): 696–98 (1988)
van Wandelen et al., J. Chrom. (1997) A, 763: 11–22
Waymouth, C., In Vitro 6: 109–127 (1970)
Waymouth, C., In: Cells and Tissues in Culture, Vol. 1, Academic Press, London, S. 99–142 (1965)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10793827B2 (en) 2010-04-23 2020-10-06 Life Technologies Corporation Cell culture medium comprising small peptides
US11365389B2 (en) 2010-04-23 2022-06-21 Life Technologies Corporation Cell culture medium comprising small peptides
US12529029B2 (en) 2010-04-23 2026-01-20 Life Technologies Corporation Cell culture medium comprising small peptides

Also Published As

Publication number Publication date
KR20170051527A (ko) 2017-05-11
DK3168295T3 (da) 2022-11-21
AU2016200611A1 (en) 2016-02-18
DK2561065T3 (en) 2017-02-13
CN110205282B (zh) 2024-07-05
AU2018202612A1 (en) 2018-05-10
US20170058256A1 (en) 2017-03-02
JP2022171839A (ja) 2022-11-11
US12529029B2 (en) 2026-01-20
WO2011133902A2 (en) 2011-10-27
SG10201609347RA (en) 2017-01-27
US10793827B2 (en) 2020-10-06
EP3168295B1 (en) 2022-11-02
JP7200180B2 (ja) 2023-01-06
DK3165600T3 (da) 2022-12-05
AU2021200418B2 (en) 2023-05-25
CN102892878A (zh) 2013-01-23
AU2021200418A1 (en) 2021-02-25
KR101733834B1 (ko) 2017-05-08
EP2561065B1 (en) 2016-11-09
SG184936A1 (en) 2012-11-29
AU2016256736A1 (en) 2016-12-01
SG10201503196VA (en) 2015-06-29
CN106520658A (zh) 2017-03-22
JP2017006127A (ja) 2017-01-12
KR20200051847A (ko) 2020-05-13
AU2018202612B2 (en) 2020-10-29
EP2561065A2 (en) 2013-02-27
US20170342371A1 (en) 2017-11-30
EP4170016A1 (en) 2023-04-26
JP6367293B2 (ja) 2018-08-01
KR102109463B1 (ko) 2020-05-12
AU2011242496B2 (en) 2015-11-19
EP3168295A1 (en) 2017-05-17
JP2020137529A (ja) 2020-09-03
CN106520658B (zh) 2024-09-24
EP3165600A1 (en) 2017-05-10
AU2011242496A1 (en) 2012-10-25
JP2018113996A (ja) 2018-07-26
US20220275325A1 (en) 2022-09-01
KR20160138316A (ko) 2016-12-02
US20200308537A1 (en) 2020-10-01
EP3165600B1 (en) 2022-11-02
KR20130106762A (ko) 2013-09-30
US11365389B2 (en) 2022-06-21
AU2011242496C1 (en) 2017-03-09
JP2017060496A (ja) 2017-03-30
KR101832795B1 (ko) 2018-02-28
KR101831549B1 (ko) 2018-02-22
AU2018202222A1 (en) 2018-04-26
JP2013524817A (ja) 2013-06-20
US20230365919A1 (en) 2023-11-16
JP7481407B2 (ja) 2024-05-10
KR20170089027A (ko) 2017-08-02
US20110262965A1 (en) 2011-10-27
JP2024099021A (ja) 2024-07-24
WO2011133902A3 (en) 2012-04-19
CN110205282A (zh) 2019-09-06
EP2561065A4 (en) 2013-07-03
KR102264580B1 (ko) 2021-06-11
KR20180023019A (ko) 2018-03-06
AU2016256736B2 (en) 2018-11-01
JP6016783B2 (ja) 2016-10-26

Similar Documents

Publication Publication Date Title
US12529029B2 (en) Cell culture medium comprising small peptides

Legal Events

Date Code Title Description
R207 Utility model specification
R150 Utility model maintained after payment of first maintenance fee after three years
R151 Utility model maintained after payment of second maintenance fee after six years
R152 Utility model maintained after payment of third maintenance fee after eight years
R071 Expiry of right